SANOFI-AVENTIS DEUTSCHLAND GMBH v. GLENMARK PHARMACEUTICALS INC., USA
2:07-cv-05855
Overview
Parties
Defendant
AVENTIS PHARMA S.A. NPE (Individual / Inventor)
Represented By
1 Attorneys ListedTOMPKINS, MCGUIRE, WACHENFELD & BARRY, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
ABBOTT LABORATORIES NPE (Individual / Inventor)
Represented By
1 Attorneys ListedTOMPKINS, MCGUIRE, WACHENFELD & BARRY, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
Abbott Laboratories, Inc. Operating Company
Represented By
1 Attorneys ListedTOMPKINS, MCGUIRE, WACHENFELD & BARRY, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
Plaintiff
ABBOTT GMBH & CO. KG Operating Company
Represented By
1 Attorneys ListedTOMPKINS, MCGUIRE, WACHENFELD & BARRY, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
SANOFI-AVENTIS DEUTSCHLAND GMBH NPE (Individual / Inventor)
Represented By
1 Attorneys ListedTOMPKINS, MCGUIRE, WACHENFELD & BARRY, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
Court & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5721244
Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
|
Filed: 1995-06-07
Issued: 1998-02-24
|
Expired (Term Ended)
Expires: 2015-06-07
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
50
Dispositive
42
Granted
7
Denied
5
Pending / Review
38
Motions by Category
Key Dispositive Motions & Rulings